Buprenorphine Cuts Risk for Death After Nonfatal, Opioid-Involved Overdose
THURSDAY, April 13, 2023 (HealthDay News) — Buprenorphine treatment after nonfatal opioid-involved overdose is associated with significant decline in the risk for opioid-involved overdose death, according to a study published online March 10 in the A…
Learn MoreDersimelagon Beneficial for Erythropoietic, X-Linked Protoporphyria
THURSDAY, April 13, 2023 (HealthDay News) — For patients with erythropoietic protoporphyria or X-linked protoporphyria, dersimelagon at doses of 100 and 300 mg significantly increases the duration of symptom-free sunlight exposure, according to a stu…
Learn MoreProphylactic Use of Tranexamic Acid Not Beneficial in Cesarean Delivery
THURSDAY, April 13, 2023 (HealthDay News) — For patients undergoing cesarean delivery, prophylactic use of tranexamic acid does not lead to a lower risk for a composite of maternal death or blood transfusion, according to a study published in the Apr…
Learn MoreGuideline Updated for Initial Management of Advanced Prostate Cancer
WEDNESDAY, April 12, 2023 (HealthDay News) — For patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen deprivation therapy (ADT),…
Learn MoreJustice Department Appeals Texas Judge’s Ruling on Abortion Pill
TUESDAY, April 11, 2023 (HealthDay News) — The U.S. Justice Department on Monday appealed a Texas court ruling that invalidates the U.S. Food and Drug Administration approval in 2020 of mifepristone, the first of two drugs taken during a medical abor…
Learn MoreJudge’s Challenge to Abortion Pill Access Brings Swift Reaction
MONDAY, April 10, 2023 (HealthDay News) — A Texas federal judge has issued a preliminary ruling that invalidates the U.S. Food and Drug Administration approval in 2000 of mifepristone, the first of two drugs most commonly taken during a medical abort…
Learn MoreAnakinra Does Not Prevent Mechanical Ventilation in Severe COVID-19 Pneumonia
MONDAY, April 10, 2023 (HealthDay News) — Anakinra is not effective in reducing the need for mechanical ventilation among patients with severe COVID-19 pneumonia, according to a study published online April 7 in JAMA Network Open.Patricia Fanlo, M.D….
Learn MoreFDA Withdraws Approval of Drug Meant to Prevent Preterm Births
THURSDAY, April 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday formally withdrew its approval of a drug that was meant to prevent preterm births.Sold as Makena (hydroxyprogesterone caproate injection), the drug was first…
Learn MoreLas recetas de opioides tras el parto aumentaron durante la pandemia
MIÉRCOLES, 5 de abril de 2023 (HealthDay News) — Las madres recientes que dieron a luz a principios de la pandemia surtieron muchas más recetas de opioides que las mujeres estadounidenses en el periodo anterior, lo que plantea preocupación sobre el p…
Learn More‘Morning After’ Antibiotics Could Slash Odds for Common STDs
THURSDAY, April 6, 2023 (HealthDay News) — A “morning after” dose of a common antibiotic can greatly lower the chances of sexually transmitted bacterial infections in high-risk people, a new clinical trial has found.Researchers discovered that taking…
Learn More